We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
+4.6%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$19.2B
AUM Growth
+$1.8B
Cap. Flow
+$1.19B
Cap. Flow %
6.18%
Top 10 Hldgs %
18.39%
Holding
141
New
19
Increased
87
Reduced
30
Closed
5

Sector Composition

Rank Sector Weight
1 Healthcare 25.06%
2 Technology 19.41%
3 Consumer Staples 14.41%
4 Industrials 13.49%
5 Financials 13.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSA icon
51
Mine Safety
MSA
$6.79B
$149M 0.78%
996,100
+37,630
+4% +$6.06M
THS
52
DELISTED
Treehouse Foods
THS
$149M 0.78%
2,851,695
-1,543,480
-35% -$73M
CTLT
53
DELISTED
CATALENT, INC.
CTLT
$148M 0.77%
1,408,980
-91,185
-6% -$10.2M
BIO icon
54
Bio-Rad Laboratories Class A
BIO
$8.76B
$148M 0.77%
259,400
+26,155
+11% +$15.5M
WWW icon
55
Wolverine World Wide
WWW
$1.68B
$148M 0.77%
3,864,235
+333,015
+9% +$11.5M
TMX
56
DELISTED
Terminix Global Holdings, Inc.
TMX
$145M 0.75%
3,038,755
+880,554
+41% +$43.4M
OKTA icon
57
Okta
OKTA
$23.8B
$145M 0.75%
656,369
+33,250
+5% +$8.36M
ASAN icon
58
Asana
ASAN
$1.96B
$144M 0.75%
5,044,650
+1,719,310
+52% +$59.4M
ATRC icon
59
AtriCure
ATRC
$2.08B
$143M 0.74%
2,175,140
+39,560
+2% +$2.44M
AIMC
60
DELISTED
Altra Industrial Motion Corp
AIMC
$142M 0.74%
2,575,205
+193,145
+8% +$11.2M
SXT icon
61
Sensient Technologies
SXT
$5.22B
$142M 0.74%
1,821,290
+33,935
+2% +$2.61M
QTWO icon
62
Q2 Holdings
QTWO
$3.78B
$141M 0.74%
1,411,535
-961,963
-41% -$120M
RBA icon
63
RB Global
RBA
$21.5B
$140M 0.73%
2,388,960
+1,639,870
+219% +$96.2M
B
64
DELISTED
Barnes Group Inc.
B
$138M 0.72%
2,794,975
+33,220
+1% +$1.74M
UMBF icon
65
UMB Financial
UMBF
$11.3B
$136M 0.71%
1,472,975
+14,645
+1% +$1.21M
CPB icon
66
Campbell Soup
CPB
$6.85B
$135M 0.7%
2,686,680
+305,260
+13% +$14.5M
CSII
67
DELISTED
Cardiovascular Systems, Inc.
CSII
$132M 0.69%
3,449,630
+378,460
+12% +$16.1M
WLY icon
68
John Wiley & Sons Class A
WLY
$2.83B
$130M 0.68%
2,397,145
+48,870
+2% +$2.49M
HRL icon
69
Hormel Foods
HRL
$14.2B
$129M 0.67%
+2,706,215
New +$128M
AVNS
70
DELISTED
Avanos Medical
AVNS
$127M 0.66%
2,912,188
-558,747
-16% -$26.2M
MKC icon
71
McCormick & Company Non-Voting
MKC
$14B
$126M 0.65%
+1,408,945
New +$125M
INSP icon
72
Inspire Medical Systems
INSP
$1.47B
$123M 0.64%
595,340
+14,680
+3% +$3.12M
BLKB icon
73
Blackbaud
BLKB
$1.94B
$120M 0.63%
1,693,895
+929,285
+122% +$64.1M
TNDM icon
74
Tandem Diabetes Care
TNDM
$1.27B
$118M 0.62%
+1,342,160
New +$125M
PEN icon
75
Penumbra
PEN
$12.6B
$117M 0.61%
430,755
-37,340
-8% -$9.64M

Similar funds

Champlain Investment Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Champlain Investment Partners held 141 positions worth $19.2B, up 10% from $17.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Champlain Investment Partners deployed $1.19B of net new capital in Q1 2021, opening 19 new positions and adding to 87 existing holdings. Its largest new stake was Clorox: 1,039,265 shares worth $200M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Ulta Beauty, an estimated $130M trimmed.

  • Champlain Investment Partners's largest Q1 2021 buy was Clorox: 1,039,265 shares worth $200M.
  • Champlain Investment Partners added most to RB Global in Q1 2021, an estimated $96.2M increase.
  • Champlain Investment Partners's biggest Q1 2021 reduction was Ulta Beauty, cutting an estimated $130M.
  • Champlain Investment Partners fully exited Pluralsight, Inc. Class A Common Stock in Q1 2021, selling an estimated $71M.
  • Champlain Investment Partners's ten largest holdings make up 18% of its $19.2B portfolio in Q1 2021.
  • Champlain Investment Partners opened 19 new positions and closed 5 in Q1 2021.
  • Champlain Investment Partners's portfolio value rose 10% quarter-over-quarter to $19.2B.

Based on Champlain Investment Partners's 13F filing for Q1 2021, filed 13 May 2021.